News Drug Development

Banyu Pharmaceutical Co. And Ono Pharmaceutical Company, Ltd. Begins Phase III Clinical Trials Of A DPP-4 Inhibitor For Type 2 Diabetes Patients

August 14, 2006 |

1 min read

Banyu Pharmaceutical Co., Ltd. and Ono Pharmaceutical Co., Ltd. will begin Phase III Clinical Trial of Sitagliptin (Development Code: MK-0431/ONO-5435) in Japan.

Clinical research Phase III Asia

MORE ON THIS TOPIC

Podcast

RFK Jr. Advances, Q4 Earnings Roll Out and a Non-Opioid Pain Drug Hits the Market

February 5, 2025

·

1 min read

·

Heather McKenzie

vial of vaccine for the vaccination plan against diseases in the China. Doctor with a vial with doses of the vaccine in front of the China flag

Earnings

Merck’s Gardasil Woes Grow as China Trade War Heats Up

February 4, 2025

·

4 min read

·

Annalee Armstrong

Young White Woman at home Holding Two Pain Killer Pills in Her Hand Palm After Spilling from Bottle and Glass of Water. Concept of Pain Relief, Addiction to Opioids and NSAIDs

Pain

Algiax’s Non-Opioid Drug Reduces Neuropathic Pain in Mid-Stage Trial

February 4, 2025

·

1 min read

·

Dan Samorodnitsky

Courtesy of 400tmax/Getty Images

Cystic Fibrosis

Cystic Fibrosis Biotech Sionna Announces $150M IPO

February 3, 2025

·

1 min read

·

Dan Samorodnitsky